Global Commercial Head - Prostate Cancer

Role: Global Commercial Head of Prostate Cancer, responsible for developing and executing global commercialization strategies for a first-in-class PARP1 inhibitor across indications including metastatic hormone-sensitive prostate cancer, breast cancer, and other prostate tumor types. Objectives include leading market shaping, competitive strategy, evidence generation, and stakeholder engagement to maximize portfolio value. Core responsibilities encompass creating launch plans, managing cross-functional Integrated Business Teams (Insights, Medical Affairs, Market Access, Diagnostics, regional teams), and aligning with senior leadership on strategic and operational plans. The role requires collaboration with global and regional teams to ensure market readiness, sustainable pricing, and access strategies, and contributing to broader oncology therapeutic strategies. Qualifications: Bachelor’s degree; 10+ years in pharmaceutical development and commercialization; proven success in launching brands both locally and globally; strong strategic, analytical, and leadership skills; experience in oncology, precision medicine, or biomarker-driven therapies preferred. High-value biopharma specifics involve oncology (prostate, breast cancer), early to late-stage development, global launch readiness, and cross-functional leadership in a matrixed organization. The position is based in Gaithersburg, MD or Cambridge, UK, with a global scope and stakeholder engagement across markets.